Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01396408
Title A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors NCIC Clinical Trials Group
Indications
Therapies
Age Groups: senior | adult
Covered Countries CAN

Additional content available in CKB BOOST